Nanobiotix S.A. (NBTX) Financials

NBTX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 146.4 million 184.5 million
Dec. 31, 2025 79.5 million 178.7 million
June 30, 2025 53.2 million 134.5 million
March 31, 2025 72.9 million 144.0 million

NBTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -26.2 million ?
Dec. 31, 2025 -19.3 million 1.6 million
June 30, 2025 -20.7 million 2.5 million
March 31, 2025 -15.2 million 2.6 million

NBTX Net Income

No data available :(

NBTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 126.5 million 83.6 million 1.4 million
Dec. 31, 2025 61.9 million 104.6 million 3.6 million
June 30, 2025 34.0 million 52.0 million 4.3 million
March 31, 2025 53.8 million - -

NBTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 55.8 million
Dec. 31, 2025 56.1 million
June 30, 2025 55.9 million
March 31, 2025 51.1 million

NBTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 725215 13.5 million 12.2 million -
Dec. 31, 2025 464889 10.1 million 10.5 million -
June 30, 2025 176799 17.1 million 13.3 million -
March 31, 2025 386206 20.1 million 21.7 million -

NBTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 6.3 million -
Dec. 31, 2025 3.5 million -
June 30, 2025 31.4 million -
March 31, 2025 -17.8 million -

NBTX

Price: $22.58

52 week price:
14.78
57.14

Payout Ratio Range:
-354.45%
-16.62%

Earnings Per Share: -1.23 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: France

Volume: 700

Market Capitalization: 1.3 billion

Links: